TherapeuticsMD
TXMD | NASDAQ
$1.81
-$0.06 (-3.21%)
At close: Nov 16, 2026, 4:00 PM ET
$1.83
+$0.02 (+1.08%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-3.21%
(1D)No price chart data available for 1D timeframe.
Rating
45.2
+8.4 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #385/1021 (Top 38%)
Key Statistics
Market Data
Market Cap $20.95M
1D Range
1.79 1.90
52W Range
1.46 2.77
Valuation (TTM)
PE 177.45
PB 0.76
EV/EBITDA -3.46
Valuation (NTM)
Forward PE 11.00
Forward PEG 28.50
Price Target $0.00
Cash Flow
FCF Yield 16.0%
SBC Adj. FCF Yield 16.0%
SBC Impact -0.2%
Margins
Gross Margin 82.2%
Operating Margin -93.5%
FCF Margin 89.7%
Growth (CAGR)
Revenue 3Y | 5Y 24.3% |
-47.1%
Dil EPS 3Y | 5Y 180.4% |
60.3%
FCF 3Y | 5Y -44.3% |
-75.0%
Returns
ROA 0.3%
ROE 0.5%
ROIC -8.1%
Financial Health
Net Cash
$5.17M
Current Ratio 3.32
Interest Coverage -3,501.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
TherapeuticsMD, Inc. is a U.S.-based pharmaceutical company dedicated to women's health. Its marketed portfolio includes IMVEXXY, prescribed for moderate to severe dyspareunia; BIJUVA, a bio-identical...
Sector Healthcare
Employees 1
IPO Date May 9, 2007
Website www.therapeuticsmd.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 13, 2026
EPS
$0.04
Beat +100.65%
YoY:
+204.65% REV
$1.3M
Miss -93.42%
YoY:
+65.82%Next Earnings
Apr 7, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove TXMD